Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
A Suzuki, Y Sakai, K Hashimoto, H Osawa… - Renal Failure, 2018 - Taylor & Francis
Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
[HTML][HTML] Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
A Suzuki, Y Sakai, K Hashimoto, H Osawa… - Renal Failure, 2018 - ncbi.nlm.nih.gov
Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
[引用][C] Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
A Suzuki, Y Sakai, K Hashimoto, H Osawa, S Tsuruoka - Renal Failure, 2018 - cir.nii.ac.jp
Kinetics of carnitine concentration after switching from oral administration to intravenous
injection in hemodialysis patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
injection in hemodialysis patients | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients
A Suzuki, Y Sakai, K Hashimoto, H Osawa… - Renal …, 2018 - pubmed.ncbi.nlm.nih.gov
Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
A Suzuki, Y Sakai, K Hashimoto, H Osawa… - Renal Failure, 2018 - europepmc.org
Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
A Suzuki, Y Sakai, K Hashimoto, H Osawa… - Renal Failure, 2018 - europepmc.org
Carnitine has high dialyzability and is often deficient in dialysis patients. This deficiency is
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …
treated by either intravenous (IV) or oral supplementation of carnitine. In this study, the mode …